Nina Lahanis
Vice President, Safety Data Management, PrimeVigilance
7 October, 2026
As a product moves beyond clinical development, safety reporting becomes less predictable, new markets bring local requirements and partner relationships add complexity. Preparing for that change means looking at governance, technology, capacity and oversight together.
In this on-demand webinar, Nina Lahanis, Vice President, Safety Data Management at PrimeVigilance, shares practical lessons from her experience across the pharmaceutical industry and PV operations. Explore how to assess readiness, strengthen oversight and build an operating model that can support commercialization and global expansion.
Vice President, Safety Data Management, PrimeVigilance
This site uses cookies to personalise and customise your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.
When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.